Body Shape Phenotypes and Breast Cancer Risk: A Mendelian Randomization Analysis.

Mendelian randomization body shape breast cancer height obesity

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
17 Feb 2023
Historique:
received: 17 12 2022
revised: 11 02 2023
accepted: 15 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

Observational and genetic studies have linked different anthropometric traits to breast cancer (BC) risk, with inconsistent results. We aimed to investigate the association between body shape defined by a principal component (PC) analysis of anthropometric traits (body mass index [BMI], height, weight, waist-to-hip ratio [WHR], and waist and hip circumference) and overall BC risk and by tumor sub-type (luminal A, luminal B, HER2+, triple negative, and luminal B/HER2 negative). We performed two-sample Mendelian randomization analyses to assess the association between 188 genetic variants robustly linked to the first three PCs and BC (133,384 cases/113,789 controls from the Breast Cancer Association Consortium (BCAC)). PC1 (general adiposity) was inversely associated with overall BC risk (0.89 per 1 SD [95% CI: 0.81-0.98];

Identifiants

pubmed: 36831637
pii: cancers15041296
doi: 10.3390/cancers15041296
pmc: PMC9954632
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : French National Cancer Institute
ID : INCA_14108

Références

J Med Screen. 2021 Jun;28(2):70-79
pubmed: 32517538
Am J Epidemiol. 2010 Jun 1;171(11):1183-94
pubmed: 20460303
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:18-31
pubmed: 31862315
BMC Med. 2018 Oct 25;16(1):187
pubmed: 30355295
Nat Commun. 2020 Jul 14;11(1):3519
pubmed: 32665587
PLoS Med. 2016 Aug 23;13(8):e1002105
pubmed: 27551723
Nat Commun. 2016 Nov 23;7:13357
pubmed: 27876822
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
Stat Med. 2017 May 20;36(11):1783-1802
pubmed: 28114746
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
BMC Med. 2021 Jan 14;19(1):10
pubmed: 33441148
Endocrinology. 2017 Jun 1;158(6):1543-1555
pubmed: 28379395
J Natl Cancer Inst. 1985 Apr;74(4):927-31
pubmed: 3857386
Clin Cancer Res. 2002 Feb;8(2):520-5
pubmed: 11839672
Stat Methods Med Res. 2007 Aug;16(4):309-30
pubmed: 17715159
BMJ. 2021 Oct 26;375:n2233
pubmed: 34702754
BMC Med. 2021 Dec 15;19(1):320
pubmed: 34906131
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
JAMA. 2021 Oct 26;326(16):1614-1621
pubmed: 34698778
Eur J Epidemiol. 2015 Jul;30(7):543-52
pubmed: 25773750
BMJ. 2020 May 06;369:m1203
pubmed: 32376654
Methods Mol Biol. 2018;1793:211-230
pubmed: 29876899
CA Cancer J Clin. 2017 Sep;67(5):378-397
pubmed: 28763097
Nat Rev Genet. 2018 Sep;19(9):566-580
pubmed: 29872216
Breast Cancer Res. 2015 May 01;17:63
pubmed: 25928287
Int J Epidemiol. 2019 Jun 1;48(3):781-794
pubmed: 31243447
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Nat Genet. 2018 May;50(5):693-698
pubmed: 29686387
Obes Rev. 2016 Nov;17(11):1167-1177
pubmed: 27432212
Crit Rev Oncol Hematol. 2007 Aug;63(2):125-49
pubmed: 17498966
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
Int J Epidemiol. 2017 Dec 1;46(6):1734-1739
pubmed: 28398548
Einstein (Sao Paulo). 2020 Mar 09;18:eAO5150
pubmed: 32159605
Bioinformatics. 2016 Oct 15;32(20):3207-3209
pubmed: 27318201
Int J Epidemiol. 2019 Jun 1;48(3):795-806
pubmed: 30277539
Br J Cancer. 2003 Apr 7;88(7):1032-4
pubmed: 12671699
Nucleic Acids Res. 2017 Jan 4;45(D1):D896-D901
pubmed: 27899670
Br J Cancer. 2023 Feb;128(4):594-605
pubmed: 36460776
Evid Based Ment Health. 2019 May;22(2):67-71
pubmed: 30979719
Cells. 2022 Sep 12;11(18):
pubmed: 36139419
Int J Epidemiol. 2016 Dec 1;45(6):1961-1974
pubmed: 27616674
BMC Cancer. 2022 Mar 8;22(1):232
pubmed: 35255844
Nat Genet. 2020 Jun;52(6):572-581
pubmed: 32424353
Int J Epidemiol. 2016 Jun;45(3):896-908
pubmed: 27427428
J Natl Cancer Inst. 2015 Aug 20;107(11):
pubmed: 26296642
Breast Cancer Res. 2005;7(3):R314-25
pubmed: 15987426
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Laia Peruchet-Noray (L)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, CEDEX 08, 69372 Lyon, France.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08007 Barcelona, Spain.

Niki Dimou (N)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, CEDEX 08, 69372 Lyon, France.

Anja M Sedlmeier (AM)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.

Béatrice Fervers (B)

Département Prévention Cancer Environnement, Centre Léon Bérard, CEDEX 08, 69373 Lyon, France.

Isabelle Romieu (I)

National Institute of Public Health, Cuernavaca 62100, Morelos, Mexico.

Vivian Viallon (V)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, CEDEX 08, 69372 Lyon, France.

Pietro Ferrari (P)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, CEDEX 08, 69372 Lyon, France.

Marc J Gunter (MJ)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, CEDEX 08, 69372 Lyon, France.

Robert Carreras-Torres (R)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), 17190 Salt, Spain.

Heinz Freisling (H)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, CEDEX 08, 69372 Lyon, France.

Classifications MeSH